The group’s principle activity is to develop photonic-based medical devices that will help improve the diagnosis and treatment of various diseases including coronary heart disease. The group’s technology includes Near-infrared diffuse reflectance spectroscopy. Customers served by the group include patients and families, physicians and hospitals, and pharmaceutical research companies. The group operates from United States.
